AnalystsFarzin HaqueFarzin Haque's Stock Forecasts
AnalystsFarzin Haque
Sectors:
Industries:
Analyst Ranking
Top 34%
#1799 out of 5256 analysts
Average Return
+65.99%
Win Rate
80%4 out of 5
Risk vs Reward
Poor
Good
Farzin Haque's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Vera Therapeutics IncVERA | +296.13% | $12.14 | $48.09 | 2023-11-09 - 2024-11-08 | Strong Buy |
Relmada Therapeutics IncRLMD | +64.14% | $4.49 | $7.37 | 2025-12-21 - 2026-04-20 | Strong Buy |
Nuvation Bio IncNUVB | +38.38% | $3.70 | $5.12 | 2025-09-29 - 2026-04-20 | Strong Buy |
Vor Biopharma IncVOR | +6.87% | $14.70 | $15.71 | 2026-03-29 - 2026-04-20 | Strong Buy |
Farzin Haque Analyst Color
Get additional color on Farzin Haque's coverage of popular stocks
Farzin Haque's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Vor Biopharma IncVOR | 1 | Strong Buy | $50.00 | +218.27% | Initiates Coverage On | 22 days ago |
Relmada Therapeutics IncRLMD | 1 | Strong Buy | $9.00 | +22.12% | Initiates Coverage On | 4 months ago |
Nuvation Bio IncNUVB | 1 | Strong Buy | $10.00 | +95.31% | Initiates Coverage On | 7 months ago |
Pyxis Oncology IncPYXS | 1 | Strong Buy | $10.00 | N/A | Assumes | 2 years ago |
Vera Therapeutics IncVERA | 1 | Strong Buy | $26.00 | N/A | Upgrades | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.